A study found that injecting mesenchymal stem cells into periocular tissue effectively reduces eye inflammation without ...

Graft-versus-host disease (GVHD) is a common and severe complication that occurs after stem cell transplantation, where the ...

Bone-marrow-derived multipotent progenitor stromal cells — or mesenchymal stem cells (MSCs) — are the common predecessors of cells of the mesenchymal lineage, such as bone, cartilage and fat ...

Atherosclerosis, a disease characterized by the accumulation of lipids and inflammatory cells in the arterial wall, is a ...

Ryoncil ® was approved in December 2024 by the United States Food and Drug Administration (FDA) for steroid-refractory acute ...

In partnership with the National Institute of Allergy and Infectious Diseases, we committed nearly $4 million over five years to co-fund a major study of mesenchymal (adult) stromal cells as a new ...

Techniques that cause multipotent adult mesenchymal stem cells (MSCs) to differentiate into cells of the chondrogenic lineage have led to a variety of experimental strategies to investigate ...

BioCardia (BCDA) announced completion of enrollment and dosing in the low dose cohort in its CardiALLO Allogeneic Mesenchymal Cell Therapy ...

Researchers from Japan have found that treatment with mesenchymal stromal cells (MSCs) increased regulatory T cells while decreasing inflammatory TH1 and TH17 cells, highlighting MSCs' potential as a ...

This important study focused on characterizing clonally derived MSC populations from the synovium of normal and osteoarthritis (OA) patients, demonstrating their potential to regenerate cartilage in ...

A variety of preclinical and clinical studies using different cell types have demonstrated variable degrees of improvement in cardiac function in models of acute myocardial infarction (MI) and ...

Dr. Shimmura explained that this therapy offers two major benefits: it reduces inflammation and promotes healing at the same ...